ContributorsPublishersAdvertisers

Dr. Perez on the Potential Utility of KIN-2787 in BRAF-Mutated Solid Tumors

onclive.com
 2022-01-19

Cesar Augusto Perez, MD, discusses the potential utility of KIN-2787 in BRAF-mutated solid tumors. Cesar Augusto Perez, MD, medical oncologist, director, Drug Development, Florida Cancer Specialists and Research Institute, Sarah Cannon Research Institute,...

www.onclive.com

Comments / 0

Comments / 0